XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated statements of changes in equity
USD ($)
shares
Stock options
USD ($)
Restricted share units
USD ($)
shares
Series C Shares
USD ($)
Public Shares
USD ($)
Share capital
USD ($)
shares
Share capital
Restricted share units
USD ($)
shares
Share capital
Series C Shares
USD ($)
shares
Share capital
Public Shares
USD ($)
shares
Contributed surplus
USD ($)
Contributed surplus
Stock options
USD ($)
Contributed surplus
Restricted share units
USD ($)
Accumulated deficit
USD ($)
Accumulated other comprehensive loss
USD ($)
Equity attributable to the Shareholders of Li-Cycle Holdings Corp.
USD ($)
Equity attributable to the Shareholders of Li-Cycle Holdings Corp.
Stock options
USD ($)
Equity attributable to the Shareholders of Li-Cycle Holdings Corp.
Restricted share units
USD ($)
Non-controlling interest (Note 15)
USD ($)
Shareholders' equity, beginning balance (in shares) at Oct. 31, 2020 | shares           83,361,291                        
Shareholders' equity, beginning balance at Oct. 31, 2020 $ 1,440,730         $ 15,441,600       $ 824,683     $ (14,528,941) $ (296,612) $ 1,440,730      
Changes in equity [abstract]                                    
Stock option expense   $ 702,932                 $ 702,932         $ 702,932    
Share issuance (in shares) | shares               11,220,218 0                  
Share issuance       $ 21,620,000 $ 0     $ 21,620,000           21,620,000      
Shares issued for non-cash costs (in shares) | shares           478,920                        
Equity issued for non-cash costs 0         $ 455,055       (455,055)                
Exercise of stock options (in shares) | shares           1,024,250                        
Exercise of stock options 169,105         $ 289,224       (120,119)         169,105      
Exercise of warrants (in shares) | shares           0                        
Exercise of warrants 0         $ 0       0                
Restricted Share Units Expense     $ 0                 $ 0            
Restricted Share Units settled in shares (in shares) | shares             0                      
Restricted share units settled     0       $ 0                      
Comprehensive loss (21,590,783)                       (21,590,783)   (21,590,783)      
Shareholders' equity, ending balance (in shares) at Jul. 31, 2021 | shares           96,084,679                        
Shareholders' equity, ending balance at Jul. 31, 2021 2,341,984         $ 37,805,879       952,441     (36,119,724) (296,612) 2,341,984      
Shareholders' equity, beginning balance (in shares) at Oct. 31, 2020 | shares           83,361,291                        
Shareholders' equity, beginning balance at Oct. 31, 2020 1,440,730         $ 15,441,600       824,683     (14,528,941) (296,612) 1,440,730      
Changes in equity [abstract]                                    
Share issuance (in shares) | shares               11,220,218 65,671,374                  
Share issuance               $ 21,620,000 $ 629,748,295                  
Shares issued for non-cash costs (in shares) | shares           478,920                        
Equity issued for non-cash costs           $ 455,055                        
Exercise of stock options (in shares) | shares           2,055,476                        
Exercise of stock options           $ 891,162                        
Restricted Share Units settled in shares (in shares) | shares             392,276                      
Restricted share units settled             $ 3,922,754                      
Shareholders' equity, ending balance (in shares) at Oct. 31, 2021 | shares           163,179,655                        
Shareholders' equity, ending balance at Oct. 31, 2021 433,721,034         $ 672,079,154       3,026,721     (241,088,229) (296,612) 433,721,034     $ 0
Changes in equity [abstract]                                    
Stock option expense 5,427,228                 5,427,228         5,427,228      
Share issuance (in shares) | shares           5,300,352                        
Share issuance $ 49,698,756         $ 49,698,756                 49,698,756      
Exercise of stock options (in shares) | shares 1,251,547         1,183,352                        
Exercise of stock options $ 0         $ 296,128       (296,128)                
Exercise of warrants (in shares) | shares           5,712,222                        
Exercise of warrants 46,001,223         $ 46,001,223       0         46,001,223      
Restricted Share Units Expense (in shares) | shares             0                      
Restricted Share Units Expense     $ 8,613,769       $ 0         8,613,769         $ 8,613,769  
Restricted Share Units settled in shares (in shares) | shares     40,404       40,404                      
Increase (Decrease) Through Exercise Of Equity Instruments             $ 533,333         $ (533,333)            
Non-controlling interest in subsidiary 330,000                                 330,000
Comprehensive loss (19,625,391)                       (19,559,341) 0 (19,559,341)     (66,050)
Shareholders' equity, ending balance (in shares) at Jul. 31, 2022 | shares           175,415,985                        
Shareholders' equity, ending balance at Jul. 31, 2022 $ 524,166,619         $ 768,608,594       $ 16,238,257     $ (260,647,570) $ (296,612) $ 523,902,669     $ 263,950